4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-21-038455
Options or other derivatives
- Director acquired 15,606 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Powell Andrew Kenneth William Director | 2021-06-03 | Grant or award · Stock Option (Right to Buy) | +12,250 | 12,250 | D: show line 1 in the form | |||||
| Powell Andrew Kenneth William Director | 2021-06-03 | Grant or award · Restricted Stock Units | +3,356 | 3,356 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…